阳民论文报告会0813：

会议主题：【Ayoungman Paper Revising(Weekly Meeting)】阳民论文报告会(周例会)
#腾讯会议ID：718  139  188
会议时间：2024/08/13日（每周二） 20:00-21:00 (GMT+08:00) 中国标准时间
重复周期：2024/08/06-2028/05/30 20:00-21:00, 每周 (周二)
点击链接入会，或添加至会议列表：
https://meeting.tencent.com/dm/Ps3CecaObUYV
【重点讨论论文】Public actor roles in market experiments: Innovating digital health markets in New York and Ireland
【注：这是FT50权威期刊《Journal of Business Research》2024年第183期论文】

Governments play critical roles in innovating the types of markets that can continue to balance market efficiencies with societal needs all while healthcare needs and associated resource demands continue to change. We suggest that market experiments by public actors might be used to innovate more equitable future market societies. We move beyond views of government as primarily confined to a regulatory role in market change and build on the market innovation literature to identify particular government roles at each stage of the market experiment, to rattle the institutional iron cage and pave the way for market innovation.

Historicity matters in market experiments as it always does in markets (

Mountford and Geiger, 2020

, 

Geiger and Bourgeron, 2023

); no market is a tabula rasa and neither are market experiments. Competition and market forces are traditionally considered essential to control costs in the U.S. healthcare market. Government, therefore, assumes that market innovation requires that they incentivize new market versions. In Ireland, on the other hand, social solidarity and means-based payment are essential. Many of those involved in healthcare would not consider themselves to be actors in a market. Financial incentivization in this context may not accomplish the same agenda. Government focus, therefore, is on actors and relationships rather than market exchanges. We close, thus, by emphasizing that the broader contexts in which market experiments take place affect what roles public actors can legitimately occupy and how successful they may be.